Lang, Jonathan F. http://orcid.org/0000-0002-7675-9625
Toulmin, Sushila A.
Brida, Kasey L.
Eisenlohr, Laurence C.
Davidson, Beverly L.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS076631)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32 GM007170)
Article History
Received: 1 April 2019
Accepted: 24 June 2019
First Online: 30 July 2019
Competing interests
: B.L.D. is a founder of Spark Therapeutics and Talee Bio, Inc. and is on the advisory boards of Homology Medicines, Prevail Therapeutics, Sarepta Therapeutics, Intellia Therapeutics and Axovant Gene Therapies. The remaining authors declare no competing interests.